MME and Alzheimer disease: NEP has been proposed as a potential therapeutic for the treatment of Alzheimer’s disease because of its activity in cleaving the amyloid-beta (Aβ) peptide [2,3] and studies have shown that increasing the level of brain NEP in animal models significantly reduces brain Aβ [4–7].